Overview

A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of MK0859 when administered alone and when in combination with atorvastatin in lowering Low Density Lipoprotein -Cholesterol (LDL-C) in Japanese patients with dyslipidemia.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Anacetrapib
Atorvastatin
Atorvastatin Calcium
Oxazolidinones